Abstract
Purpose
PET has been demonstrated to be sensitive for detecting active inflammation in Takayasu’s arteritis (TAK) patients, but semi-quantitative-based assessment may be susceptible to various biological and technical factors. Absolute quantification via dynamic PET (dPET) may provide a more reliable and quantitative assessment of TAK-active arteries. The purpose of this study was to investigate the feasibility and efficacy of dPET in quantifying TAK-active arteries compared to static PET.
Materials and methods
This prospective study enrolled 10 TAK-active patients (fulfilled the NIH criteria) and 5 control participants from March to October 2022. One-hour dPET scan (all TAK and control participants) and delayed static PET scan at 2-h (all TAK patients) were acquired. For 1-h static PET, summed images from 50 to 60 min of the dPET were extracted. PET parameters derived from 1- and 2-h static PET including SUV (SUV1H and SUV2H), target-to-background ratio (TBR) (TBR1H and TBR2H), net influx rate (Ki), and TBRKi extracted from dPET were obtained. The detectability of TAK-active arteries was compared among different scanning methods using the generalized estimating equation (GEE) with a logistic regression with repeated measures, and the GEE with gamma distribution and log link function was used to evaluate the different study groups or scanning methods.
Results
Based on the disease states, 5 cases of TAK were classified as untreated and relapsed, respectively. The SUVmax on 2-h PET was higher than that on 1-h PET in the untreated patients (P < 0.05). However, no significant differences were observed in the median SUVmax between 1-h PET and 2-h PET in the relapsed patients (P > 0.05). The TBRKi was significantly higher than both TBR1H and TBR2H (all P < 0.001). Moreover, the detectability of TAK-active arteries by dPET-derived Ki was significantly higher than 1-h and 2-h PET (all P < 0.001). Significant differences were observed in Kimax, SUVmax-1H, TBR1H, and TBRKi among untreated, relapsed, and control groups (all P < 0.05).
Conclusions
Absolute quantitative assessment by dPET provides an improved sensitivity and detectability in both visualization and quantification of TAK-active arteries. This elucidates the clinical significance of dPET in the early detection of active inflammation and monitoring recurrence.
Similar content being viewed by others
Data availability
Data are available on request to the corresponding author.
Code availability
Not applicable.
Abbreviations
- TAK:
-
Takayasu’s arteritis
- [18F]FDG:
-
2-Deoxy-2-[18F]fluoro-D-glucose
- PET:
-
Positron emission tomography
- SUV:
-
Standardized uptake value
- TBR:
-
Target-to-background ratio
- SNR:
-
Signal-to-noise ratio
References
Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994;90:1855–60.
Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022;81(12):1654–60.
de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.
Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Radiol. 2015;70(7):787–800.
Einspieler I, Thürmel K, Pyka T, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: A pilot study. Eur J Nucl Med Mol Imaging. 2015;42(7):1012–24.
Gheysens O, Jamar F, Glaudemans AWJM, Yildiz H, van der Geest KSM. Semi-quantitative and quantitative [18F]FDG-PET/CT indices for diagnosing large vessel vasculitis: A critical review. Diagnostics (Basel). 2021;11(12):2355.
Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310–20.
Choi JY, Yang J, Noworolski SM, et al. 18F fluorocholine dynamic time-of-flight PET/MR imaging in patients with newly diagnosed intermediate- to high-risk prostate cancer: Initial clinical-pathologic comparisons. Radiology. 2017;282(2):429–36.
Wardak M, Sonni I, Fan AP, et al. 18F-FSPG PET/CT imaging of system xC- transporter activity in patients with primary and metastatic brain tumors. Radiology. 2022;303(3):620–31.
Wang Y, Li E, Cherry SR, Wang G. Total-body PET kinetic modeling and potential opportunities using deep learning. PET clinics. 2021;16:613–25.
Spencer BA, Berg E, Schmall JP, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2–2018 with additional tests to characterize pet scanners with a long axial field of view. J Nucl Med. 2021;62(6):861–70.
Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: Transforming the role of positron emission tomography. Sci Transl Med. 2017;9(381):eaaf6169.
Sari H, Mingels C, Alberts I, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022;49(6):1997–2009.
Duan Y, Wang X, Cheng Z. Immunoglobulin G4-related aortitis/periaortitis: Total-body 18F-fluorodeoxyglucose positron emission tomography dynamic imaging. Circ Cardiovasc Imaging. 2023;16(3): e014176.
Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54:S141–7.
Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.
Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–29.
Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol. 2021;73(8):1349–65. https://doi.org/10.1002/art.41774.
Grayson PC, Alehashemi S, Bagheri AA, et al. 18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70(3):439–49.
Incerti E, Tombetti E, Fallanca F, et al. 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44(7):1109–18.
Quinn KA, Rosenblum JS, Rimland CA, Gribbons KB, Ahlman MA, Grayson PC. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis. Semin Arthritis Rheum. 2020;50(1):71–6.
Martínez-Rodríguez I, del Castillo-Matos R, Quirce R, et al. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET/CT in large vessel vasculitis. Rev Esp Med Nucl Imagen Mol. 2013;32(4):222–6.
Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC. . Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: Evaluation of 103 dynamic whole-body 18F-FDG PET/CT scans [published correction appears in Eur J Nucl Med Mol Imaging. 2021 Feb 13;]. Eur J Nucl Med Mol Imaging. 2021;48(3):837–50.
Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15(3):345–52.
Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CT in Takayasu arteritis: Sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5(4):422–9.
Houshmand S, Salavati A, Segtnan EA, Grupe P, Høilund-Carlsen PF, Alavi A. Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings. PET Clin. 2016;11(1):65–84.
Shinya T, Otomi Y, Kubo M, et al. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: A prospective study. Ann Nucl Med. 2019;33(6):414–23.
Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48(1):21–39.
Fu F, Li X, Wu Y, et al. Total-body dynamic PET/CT of micro-metastatic lymph node in a patient with lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1678–9.
Kobayashi Y, Ishii K, Oda K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46(6):917–22.
Incerti E, Tombetti E, Fallanca F, et al. (18)F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44:1109–18.
Barra L, Kanji T, Malette J, Pagnoux C; CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmun Rev. 2018;17(2):175–187.
Acknowledgements
We would like to thank Qi Ge (Central Research Institute, UIH Group) for her valuable advice and support on the statistical analysis of the data.
Funding
This study was supported by National Natural Science Foundation of China Grants (82202235), Natural Science Foundation of Shandong Province (ZR2022MH165) and the Academic Promotion Program of Shandong First Medical University (2019LJ005).
Author information
Authors and Affiliations
Contributions
Study conception and design: Yanhua Duan, Li Chen, Ximing Wang and Zhaoping Cheng. Material preparation, data collection and analysis were performed by Yanhua Duan, Keyu Zan, Minjie Zhao, Yee Ling Ng, Hui Li, Min Ge, Leiying Chai, Xiao Cui, Wenjin Quan and Kun Li. The first draft of the manuscript was written by Yanhua Duan, and all authors commented on previous versions of the manuscript. Manuscript revision: Yun Zhou, Li Chen, Ximing Wang and Zhaoping Cheng. All authors commented on previous versions of the manuscript and read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This prospective study was performed from March 2022 to October 2022 with approval from the Hospital Ethics Committee (no.2022-S377).
Consent to participate
All the enrolled patients have signed the informed consent prior to the examination.
Consent for publication
Patients signed informed consent regarding publishing their data and photographs for scientific use.
Conflict of interest
Y.Ng. and Y.Z. are full-time employees of United Imaging Healthcare, China, and have no relevant financial or non-financial interests to disclose. All the other authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Yanhua Duan is first author.
Key points
dPET-derived Ki demonstrated a higher detectability of active arteries than static PET-derived SUVs in both untreated (69.5% vs 49.5% vs 36.8%, respectively, P < 0.001) and relapsed Takayasu’s arteritis patients (69.5% vs 42.1% vs 16.8%, respectively, P < 0.001).
dPET is feasible in a clinical setting and the utilization of quantitative dPET-derived TBR proves to be a more sensitive parameter compared to static PET-derived TBRs in both untreated and relapsed patients (all P < 0.001).
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 (MP4 1962 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Duan, Y., Zan, K., Zhao, M. et al. The feasibility of quantitative assessment of dynamic 18F-fluorodeoxyglucose PET in Takayasu’s arteritis: a pilot study. Eur J Nucl Med Mol Imaging 51, 81–92 (2023). https://doi.org/10.1007/s00259-023-06429-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-023-06429-4